Description
Highly absorbable form of diindolylmethane to support breast, cervical and prostate health‡
Benefits & Features
- Potential support for maintaining the function of healthy breast cells and breast comfort‡
- Promotes cervical and prostate cell health‡
- Supports healthy cell cycle function and signal transduction‡
- Offers BioResponse DIM® , specially developed for enhanced absorption
- Formulated with ingredients naturally found in vegetables like broccoli, kale and Brussels sprouts
- Made with vegan ingredients
Indications
- Ages 18 and up
- Breast, cervical and prostrate health support‡
Suggested Use
As a dietary supplement, take 1 capsule, 1-3 times daily, with or between meals.
Science & Research
Verifiable Science
DIMPRO® 100 contains BioResponse DIM® (diindolylmethane complex). Diindolylmethane is a metabolite of indole-3-carbinol (I3C). Both are metabolites of glucosinolates found naturally in cruciferous vegetables like broccoli, kale and Brussels sprouts. Upon contact with gastric acid in the stomach, I3C is converted to a number of active compounds, predominantly diindolylmethane. Research indicates that diindolylmethane supports healthy cell cycle function and signal transduction to maintain breast, cervical and prostate cell health.1,2,3 In a double-blind, randomized clinical trial, BioResponse DIM® revealed potential support for maintaining the function of healthy breast cells.4 Another randomized placebo-controlled crossover trial found that it promoted statistically significant breast comfort.5 Furthermore, an additional doubleblind, randomized clinical trial with 52 women found that BioResponse DIM® supported cervical cell health.6 Diindolylmethane in its pure form is highly insoluble. Patented, microencapsulated BioResponse DIM® has been specially developed for enhanced solubility and absorption.7 This form may be more supportive than I3C in cases of low gastric acidity. ‡
References
- Ahmad A, et al. Int J Cancer. 2011 Oct 1;129(7):1781-91.
- Zeligs MA, et al. JAJA. 2005. 8(1); 10-20.
- Kong D, et al. Cancer Res. 2007 Apr 1;67(7):3310-9.
- Dalessandri KM, et al. Nutr Cancer.2004;50(2):161-7.
- Zeligs MA, et al. JAJA. 2005. 8(1); 10-20.
- Del Priore G, et al. Gynecol Oncol. 2010 Mar;116(3):464-7.
- Anderton MJ, et al. Drug Metab Dispos. 2004 Jun;32(6):632-8.
